Importantly, our findings also identify a novel, positive correlation between the expression of α3β1 (assessed by staining for the α3 subunit) and COX2 in clinical samples of human IDC, thereby validating the clinical relevance of our earlier report that α3β1 regulates COX2 expression in a preclinical breast cancer model [11]. Here, PTGS2 is linked to breast carcinoma.